Chronic Kidney Disease Care
People with chronic kidney disease (CKD) have high rates of hospitalization and cardiovascular events, disability, and premature death. 1% of CKD patients have severe, non-reversible kidney damage (end-stage renal disease—ESRD). Americans with CKD incur roughly $315 billion in annual health spending and account for almost a quarter of Medicare spending—over $121 billion annually. Patients who progress to ESRD incur health spending in excess of $87,000 per person per year.
Opportunities for savings
Our estimate of net savings from national implementation of the CERC CKD model is $63 billion dollars in direct healthcare spending per year—20% of the estimated $315 billion spent each year on CKD by public and private payers.
Safely reducing annual per capita CKD care spending
The key elements of the model include:
- More proactive identification and treatment of patients with early-stage CKD to slow disease progression and its high costs
- Cost-efficient coordination of care for patients approaching ESRD to prevent costly, unnecessary hospitalization and emergency room visits and to establish the least hazardous form of vascular access for those patients who prefer hemo-dialysis to treat end-stage disease
- Assuring that patients have an opportunity to select a treatment for ESRD that best fits their personal preferences. This includes the opportunity to select home-based treatment options such as overnight peritoneal dialysis, which are much less costly and physically exhausting than care in dialysis centers.